Earnings Strength: Recent discussions on X about Procter & Gamble (PG) have centered on the company’s Q1 FY26 earnings, which exceeded expectations with robust net income and revenue. Many users are impressed by the firm’s resilience, pointing to its steady guidance amid economic pressures. This has fueled conversations about PG’s reliability in the consumer goods space.
Stock Price Drop: Another focal point on X is the recent decline in PG’s stock price, with some noting it as a potential opportunity for investors. Posts highlight a drop to around $146.85, sparking debates on whether this reflects broader market trends or company-specific concerns. The chatter also ties this to institutional outflows, adding a layer of uncertainty.
Institutional Activity: Discussions on X also touch on significant institutional selling, with reports of hundreds of funds exiting positions in PG. This has led to speculation about market skepticism, though some argue the stock’s defensive nature and dividend appeal remain strong. The upcoming strategic updates are seen as a potential catalyst.
Note: This discussion summary was generated from an AI condensation of post data.
Procter & Gamble Insider Trading Activity
Procter & Gamble insiders have traded $PG stock on the open market 25 times in the past 6 months. Of those trades, 0 have been purchases and 25 have been sales.
Here’s a breakdown of recent trading of $PG stock by insiders over the last 6 months:
- JON R MOELLER (Chairman, President and CEO) has made 0 purchases and 2 sales selling 51,803 shares for an estimated $8,088,342.
- SHAILESH JEJURIKAR (Chief Operating Officer) has made 0 purchases and 2 sales selling 17,025 shares for an estimated $2,657,488.
- ANDRE SCHULTEN (Chief Financial Officer) has made 0 purchases and 3 sales selling 15,891 shares for an estimated $2,477,831.
- R. ALEXANDRA KEITH (CEO - Beauty) has made 0 purchases and 4 sales selling 13,717 shares for an estimated $2,156,107.
- GARY A COOMBE (CEO - Grooming) has made 0 purchases and 2 sales selling 13,729 shares for an estimated $2,150,411.
- JENNIFER L. DAVIS (CEO - Health Care) has made 0 purchases and 2 sales selling 11,823 shares for an estimated $1,843,177.
- MARC S. PRITCHARD (Chief Brand Officer) sold 9,849 shares for an estimated $1,548,989
- SUNDAR G. RAMAN (CEO-Fabric & Home Care) sold 9,554 shares for an estimated $1,511,050
- SUSAN STREET WHALEY (Chief Legal Officer & Secy) has made 0 purchases and 3 sales selling 9,575 shares for an estimated $1,493,316.
- MA. FATIMA FRANCISCO (CEO - Baby, Fem & Family Care) sold 9,100 shares for an estimated $1,431,191
- BALAJI PURUSHOTHAMAN (Chief Human Resources Officer) has made 0 purchases and 2 sales selling 1,096 shares for an estimated $169,901.
- MATTHEW W. JANZARUK (SVP - Chief Accounting Officer) has made 0 purchases and 2 sales selling 1,044 shares for an estimated $158,608.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Procter & Gamble Congressional Stock Trading
Members of Congress have traded $PG stock 18 times in the past 6 months. Of those trades, 8 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $PG stock by members of Congress over the last 6 months:
- REPRESENTATIVE MARJORIE TAYLOR GREENE purchased up to $50,000 on 11/06.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. purchased up to $15,000 on 10/17.
- REPRESENTATIVE VAL T. HOYLE has traded it 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 09/23, 07/02.
- REPRESENTATIVE DAVID TAYLOR has traded it 4 times. They made 4 purchases worth up to $60,000 on 09/22, 08/13, 08/07 and 0 sales.
- REPRESENTATIVE KATHERINE M. CLARK has traded it 2 times. They made 0 purchases and 2 sales worth up to $100,000 on 09/17.
- REPRESENTATIVE TIM MOORE sold up to $15,000 on 09/10.
- REPRESENTATIVE JULIE JOHNSON sold up to $15,000 on 08/14.
- REPRESENTATIVE ADAM SMITH sold up to $15,000 on 08/08.
- REPRESENTATIVE RITCHIE TORRES sold up to $15,000 on 07/11.
- REPRESENTATIVE LISA C. MCCLAIN has traded it 2 times. They made 1 purchase worth up to $15,000 on 06/24 and 1 sale worth up to $15,000 on 07/10.
- REPRESENTATIVE SCOTT FRANKLIN sold up to $50,000 on 06/16.
- REPRESENTATIVE CLIFF BENTZ purchased up to $15,000 on 06/06.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Procter & Gamble Hedge Fund Activity
We have seen 1,658 institutional investors add shares of Procter & Gamble stock to their portfolio, and 2,082 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- KINGSTONE CAPITAL PARTNERS TEXAS, LLC removed 76,019,740 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $11,680,433,051
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 15,836,299 shares (+70.3%) to their portfolio in Q3 2025, for an estimated $2,433,247,341
- BLACKROCK, INC. added 6,580,590 shares (+3.8%) to their portfolio in Q3 2025, for an estimated $1,011,107,653
- GQG PARTNERS LLC removed 2,708,435 shares (-56.7%) from their portfolio in Q3 2025, for an estimated $416,151,037
- WELLINGTON MANAGEMENT GROUP LLP removed 2,483,736 shares (-17.9%) from their portfolio in Q3 2025, for an estimated $381,626,036
- AMUNDI added 2,222,560 shares (+26.3%) to their portfolio in Q3 2025, for an estimated $341,496,344
- ALLIANCEBERNSTEIN L.P. removed 2,035,036 shares (-34.6%) from their portfolio in Q3 2025, for an estimated $312,683,281
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Procter & Gamble Analyst Ratings
Wall Street analysts have issued reports on $PG in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 09/25/2025
- UBS issued a "Buy" rating on 07/17/2025
To track analyst ratings and price targets for Procter & Gamble, check out Quiver Quantitative's $PG forecast page.
Procter & Gamble Price Targets
Multiple analysts have issued price targets for $PG recently. We have seen 8 analysts offer price targets for $PG in the last 6 months, with a median target of $172.0.
Here are some recent targets:
- Andrea Teixeira from JP Morgan set a target price of $165.0 on 10/27/2025
- Olivia Tong from Raymond James set a target price of $175.0 on 10/20/2025
- Olivia Tong from B of A Securities set a target price of $174.0 on 10/08/2025
- Peter Grom from UBS set a target price of $176.0 on 10/08/2025
- Lauren Lieberman from Barclays set a target price of $153.0 on 10/01/2025
- Chris Carey from Wells Fargo set a target price of $170.0 on 09/25/2025
- Kevin Grundy from BNP Paribas set a target price of $177.0 on 08/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
